Insider Tracker SEC Form 4 insider trades
← All clusters
BMRA

BIOMERICA INC

Healthcare In Vitro & In Vivo Diagnostic Substances Market cap: $8.1M All insider activity → Quote and statistics → Sign in to watch BMRA Sign in to set a price alert
46
Insider Score Band below 60

AI score not needed: the AI review runs from a match score of 55.

Research score, not a recommendation.

Total bought$21.8K4 Form 4 purchases
Distinct insiders3open-market buyers
Lead insiderIrani Zackary S.CEO
Cluster window2023-01-24 → 2023-01-27closed

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders
37%
Seniority executive rank of buyers (CEO/CFO/Director)
95%
Commitment purchase size relative to company & holdings
39%
Context buying into stock weakness signals conviction
55%
Timing coordinated purchases within a tight window
100%
Routine-purchase discount × 1.00
Company-type / offering discount × 1.00
Net insider selling penalty − 0

Why are they buying?

AI score not needed: the AI review runs only on clusters with a match score of 55 or more. The filings in the table below are the primary evidence.

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

4 Form 4 trades · 3 insiders Sign in to download CSV
Purchases in this cluster, grouped by insider, largest first
Date Insider Role Shares Price Value Filing
2023-01-24 → 2023-01-25 Irani Zackary S. 15 purchases with a 63-day result · median -22.1% CEO 3,800 $2.83 avg $10.8K
2023-01-24 Irani Zackary S. 2,000 $2.81 $5.6K SEC filing for Irani Zackary S. (opens in a new tab)
2023-01-25 Irani Zackary S. 1,800 $2.85 $5.1K SEC filing for Irani Zackary S. (opens in a new tab)
2023-01-26 Coste Catherine history of Coste Catherine's purchases Director 2,190 $2.96 $6.5K SEC filing for Coste Catherine (opens in a new tab)
2023-01-27 BARBIERI ALLEN history of BARBIERI ALLEN's purchases Chair 1,538 $2.94 $4.5K SEC filing for BARBIERI ALLEN (opens in a new tab)
Total $21.8K

Other buying runs at BMRA

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days -22.3%63 days -44.4%126 days -45.3%

Other insider buying runs at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days63 days126 days Status
2026-08-20 → 2026-08-26 5 $158.0K 58 +14.6%–– active
2016-08-01 → 2016-10-03 7 $135.9K 48 -15.1%-42.1%-36.9% closed